Linkedin Facebook Twitter Youtube

20 Jul Papillon Therapeutics

Posted at 16:20h in by


Stephanie Cherqui, Ph.D., Scientific Co-Founder and Professor of Pediatrics

Oct. 11 | 9:30am | Ecolab Life Sciences Ballroom 

San Diego, CA

(Private)

Papillon Therapeutics is a biotechnology company advancing new therapies tailored to address lysosomal and mitochondrial dysfunctions that underly life-threating inherited conditions, such as Friedreich’s ataxia. We specialize in developing gene-modified hematopoietic stem and progenitor cell (HSPC) therapies, leveraging the natural capacity of these unique human cells to perform multi-systemic repair of damaged tissues. Our pipeline includes a partnered Ph1/2 clinical stage program that recently reported positive data for a gene-modified HSPC therapeutic candidate, and multiple preclinical stage programs that benefit from this clinical program.

www.papillon-tx.com



About the Event

The Cell & Gene Meeting on the Mesa is the sector’s foremost annual conference bringing together senior executives and top decision-makers in the industry to advance cutting-edge research into cures. Tackling the commercialization hurdles facing the cell and gene therapy sector today, this meeting covers a wide range of topics from clinical trial design to alternative payment models to scale-up and supply chain platforms for advanced therapies. The program features expert-led panels, extensive partnering capabilities, exclusive networking opportunities, and 100+ dedicated presentations by the leading publicly traded and privately held companies in the space. Attracting over 2,000 attendees – over 20% of which are C-level executives – this conference enables key partnerships through more than 5,000 one-on-one meetings while highlighting the significant clinical and commercial progress in the field.

Dates & Location

October 7-9, 2024
Arizona Biltmore
Phoenix, AZ

Program Organizer

By using this website you agree to accept our Privacy Policy and Terms & Conditions